General management
- PMID: 15757811
- DOI: 10.1016/j.bpg.2004.11.001
General management
Abstract
Hepatocellular carcinoma is one of the most common malignancies worldwide. The general management of hepatocellular carcinoma begins with an accurate diagnosis. With advances in imaging studies, noninvasive diagnosis has become an accepted standard of care for hepatocellular carcinoma, though pathologic examination is still required in selected cases. Following diagnosis, accurate staging is the next most important step in selecting the most appropriate treatment modality. Patients with localised tumor and compensated liver disease should be considered for partial hepatectomy, and patients with poor hepatic function but early tumor stage are candidates for liver transplantation. Patients who do not qualify for either of these curative treatments may be evaluated for palliative therapy, of which transarterial chemoembolisation is most widely used. This review will discuss the role of biopsy, the pros and cons of noninvasive and pathologic tissue diagnosis as well as the general approach to choose the most appropriate treatment for patients with hepatocellular carcinoma.
Similar articles
-
The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.Liver Transpl. 2004 Feb;10(2 Suppl 1):S115-20. doi: 10.1002/lt.20034. Liver Transpl. 2004. PMID: 14762851 Review.
-
Treatment of hepatocellular carcinoma.Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):129-45. doi: 10.1016/j.bpg.2004.11.008. Best Pract Res Clin Gastroenterol. 2005. PMID: 15757809 Review.
-
Management of hepatocellular carcinoma.Rev Gastroenterol Disord. 2003 Winter;3(1):8-24. Rev Gastroenterol Disord. 2003. PMID: 12684589 Review.
-
[Diagnosis and multimodal therapy for hepatocellular carcinoma].Z Gastroenterol. 2010 Feb;48(2):274-88. doi: 10.1055/s-0028-1109901. Epub 2010 Jan 29. Z Gastroenterol. 2010. PMID: 20119895 Review. German.
-
Modern diagnosis and management of hepatocellular carcinoma.Clin Liver Dis. 2009 May;13(2):233-47. doi: 10.1016/j.cld.2009.02.007. Clin Liver Dis. 2009. PMID: 19442916
Cited by
-
Ambovex(®) as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial.J Hepatocell Carcinoma. 2015 Jun 22;2:79-89. doi: 10.2147/JHC.S60864. eCollection 2015. J Hepatocell Carcinoma. 2015. PMID: 27508197 Free PMC article.
-
Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.Dig Dis Sci. 2009 Dec;54(12):2712-21. doi: 10.1007/s10620-009-1015-x. Epub 2009 Oct 30. Dig Dis Sci. 2009. PMID: 19876735
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous